Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $4.61 $6.39 Thursday, 9th May 2024 AFMD stock ended at $5.24. This is 0.0956% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.82% from a day low at $5.14 to a day high of $5.28.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Oct 20, 2016 $25.00 $25.00 $25.00 $25.00 8 860
Oct 19, 2016 $24.00 $24.00 $24.00 $24.00 8 490
Oct 18, 2016 $23.00 $23.00 $23.00 $23.00 7 640
Oct 17, 2016 $22.00 $22.00 $22.00 $22.00 9 540
Oct 14, 2016 $23.40 $23.40 $23.40 $23.40 8 860
Oct 13, 2016 $24.20 $24.20 $24.20 $24.20 13 400
Oct 12, 2016 $24.10 $24.10 $24.10 $24.10 12 140
Oct 11, 2016 $24.10 $24.10 $24.10 $24.10 10 350
Oct 10, 2016 $25.00 $25.00 $25.00 $25.00 6 860
Oct 07, 2016 $24.70 $24.70 $24.70 $24.70 13 050
Oct 06, 2016 $25.40 $25.40 $25.40 $25.40 15 760
Oct 05, 2016 $26.90 $26.90 $26.90 $26.90 12 230
Oct 04, 2016 $25.90 $25.90 $25.90 $25.90 15 550
Oct 03, 2016 $26.30 $26.30 $26.30 $26.30 21 080
Sep 30, 2016 $27.80 $27.80 $27.80 $27.80 7 120
Sep 29, 2016 $27.30 $27.30 $27.30 $27.30 6 400
Sep 28, 2016 $28.30 $28.30 $28.30 $28.30 5 760
Sep 27, 2016 $28.40 $28.40 $28.40 $28.40 18 380
Sep 26, 2016 $28.20 $28.20 $28.20 $28.20 5 550
Sep 23, 2016 $29.40 $29.40 $29.40 $29.40 23 180
Sep 22, 2016 $30.00 $30.00 $30.00 $30.00 90 380
Sep 21, 2016 $30.40 $30.40 $30.40 $30.40 7 550
Sep 20, 2016 $29.50 $29.50 $29.50 $29.50 5 550
Sep 19, 2016 $29.60 $29.60 $29.60 $29.60 2 720
Sep 16, 2016 $29.80 $29.80 $29.80 $29.80 6 220
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT